LY450108

CAS No. 376594-67-1

LY450108( —— )

Catalog No. M29625 CAS No. 376594-67-1

LY450108 is a potentiator of the AMPA receptor that can be used in Parkinson's disease studies.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 160 Get Quote
10MG 260 Get Quote
25MG 465 Get Quote
50MG 673 Get Quote
100MG 945 Get Quote
500MG 1881 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LY450108
  • Note
    Research use only, not for human use.
  • Brief Description
    LY450108 is a potentiator of the AMPA receptor that can be used in Parkinson's disease studies.
  • Description
    LY450108 is a potentiator of the AMPA receptor that can be used in Parkinson's disease studies.
  • In Vitro
    AMPA receptors mediate most of the excitatory neurotransmission and play a key role in synaptic plasticity in the mammalian central nervous system (CNS). Recent evidence has shown that in addition to modulating fast synaptic plasticity and memory processes, AMPA receptor potentiators alter downstream signalling pathways and may thereby have utility in other CNS disorders.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    iGluR
  • Recptor
    iGluR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    376594-67-1
  • Formula Weight
    396.45
  • Molecular Formula
    C19H22F2N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 50 mg/mL (126.12 mM)
  • SMILES
    CC(C)S(NC[C@H](C)c(cc1)ccc1NC(c1cc(F)cc(F)c1)=O)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • JNJ-61432059

    JNJ-61432059 is an oral active and selective negative modulator of TARP γ?8 Selective AMPAR(pIC50: 9.7).

  • L-701324

    A potent, orally active antagonist at the glycine modulatory site on NMDA receptor with IC50 of 2 nM.

  • UK-240455

    UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment.